Nemaura Medical Inc.: Nasdaq/NYSE listing notice — Nemaura Medical receives Nasdaq non-compliance notice for late 10-Q, regained compliance after filing

Nemaura Medical Inc.

Nasdaq notified Nemaura on Feb 23, 2023 of failure to timely file Form 10-Q for quarter ended Dec 31, 2022.
Company filed the overdue Form 10-Q on Feb 24, 2023.
Nasdaq confirmed compliance on Feb 27, 2023 and closed the matter.
Press release issued March 9, 2023 to disclose the notice and resolution.

item 3.01 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

Nemaura Medical Inc. received a nasdaq noncompliance notice notice regarding late filing (rules 5250(c)(1)).

Exchange: nasdaq
Notice: noncompliance notice
Deficiency: late filing
Rules: 5250(c)(1)

Exact text from the filing

February 23, 2023, the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notified Nemaura Medical Inc. (the “Company”) that it was not in compliance with Nasdaq’s continued listing requirements under Nasdaq Listing Rule 5250(c)(1) (the “Rule”) as a result of its failure to timely file its Quarterly Report on Form 10-Q for the quarter ended December 31, 2022 (the “Form 10-Q”). Subsequently, on February 24, 2023, the Company filed the Form 10-Q and regained compliance with the Rule. On February 27, 2023, the Company received a notice from Nasdaq that, based on the Form

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001079973-23-000298

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.